BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29781813)

  • 21. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1.
    Li X; Gounari F; Protopopov A; Khazaie K; von Boehmer H
    J Exp Med; 2008 Nov; 205(12):2851-61. PubMed ID: 18981238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors.
    Sharma A; Gadkari RA; Ramakanth SV; Padmanabhan K; Madhumathi DS; Devi L; Appaji L; Aster JC; Rangarajan A; Dighe RR
    Sci Rep; 2015 Jun; 5():11012. PubMed ID: 26046801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species.
    Giambra V; Jenkins CR; Wang H; Lam SH; Shevchuk OO; Nemirovsky O; Wai C; Gusscott S; Chiang MY; Aster JC; Humphries RK; Eaves C; Weng AP
    Nat Med; 2012 Nov; 18(11):1693-8. PubMed ID: 23086478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.
    Gekas C; D'Altri T; Aligué R; González J; Espinosa L; Bigas A
    Leukemia; 2016 Oct; 30(10):2002-2010. PubMed ID: 27125305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notch1 and IL-7 receptor signalling in early T-cell development and leukaemia.
    González-García S; García-Peydró M; Alcain J; Toribio ML
    Curr Top Microbiol Immunol; 2012; 360():47-73. PubMed ID: 22695916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies.
    Treanor LM; Volanakis EJ; Zhou S; Lu T; Sherr CJ; Sorrentino BP
    Blood; 2011 May; 117(20):5453-62. PubMed ID: 21427293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.
    Vilimas T; Mascarenhas J; Palomero T; Mandal M; Buonamici S; Meng F; Thompson B; Spaulding C; Macaroun S; Alegre ML; Kee BL; Ferrando A; Miele L; Aifantis I
    Nat Med; 2007 Jan; 13(1):70-7. PubMed ID: 17173050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SIRT1 regulates the phosphorylation and degradation of P27 by deacetylating CDK2 to promote T-cell acute lymphoblastic leukemia progression.
    Wang F; Li Z; Zhou J; Wang G; Zhang W; Xu J; Liang A
    J Exp Clin Cancer Res; 2021 Aug; 40(1):259. PubMed ID: 34407842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.
    Hu Y; Su H; Liu C; Wang Z; Huang L; Wang Q; Liu S; Chen S; Zhou J; Li P; Chen Z; Liu H; Qing G
    Oncogene; 2017 Feb; 36(8):1038-1047. PubMed ID: 27593934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.
    Herranz D; Ambesi-Impiombato A; Palomero T; Schnell SA; Belver L; Wendorff AA; Xu L; Castillo-Martin M; Llobet-Navás D; Cordon-Cardo C; Clappier E; Soulier J; Ferrando AA
    Nat Med; 2014 Oct; 20(10):1130-7. PubMed ID: 25194570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOTCH1-Induced T-Cell Acute Lymphoblastic Leukemia In Vivo Models.
    Campagnari A; Belver L
    Methods Mol Biol; 2024; 2773():9-24. PubMed ID: 38236532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia.
    Sanda T; Li X; Gutierrez A; Ahn Y; Neuberg DS; O'Neil J; Strack PR; Winter CG; Winter SS; Larson RS; von Boehmer H; Look AT
    Blood; 2010 Mar; 115(9):1735-45. PubMed ID: 20007543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.
    Efimenko E; Davé UP; Lebedeva IV; Shen Y; Sanchez-Quintero MJ; Diolaiti D; Kung A; Lannutti BJ; Chen J; Realubit R; Niatsetskaya Z; Ten V; Karan C; Chen X; Califano A; Diacovo TG
    Mol Cancer Ther; 2017 Oct; 16(10):2069-2082. PubMed ID: 28716817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotactic Cues for NOTCH1-Dependent Leukemia.
    Piovan E; Tosello V; Amadori A; Zanovello P
    Front Immunol; 2018; 9():633. PubMed ID: 29666622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling.
    Medyouf H; Gusscott S; Wang H; Tseng JC; Wai C; Nemirovsky O; Trumpp A; Pflumio F; Carboni J; Gottardis M; Pollak M; Kung AL; Aster JC; Holzenberger M; Weng AP
    J Exp Med; 2011 Aug; 208(9):1809-22. PubMed ID: 21807868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia.
    Saccomani V; Grassi A; Piovan E; Bongiovanni D; Di Martino L; Minuzzo S; Tosello V; Zanovello P
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells.
    Allman D; Karnell FG; Punt JA; Bakkour S; Xu L; Myung P; Koretzky GA; Pui JC; Aster JC; Pear WS
    J Exp Med; 2001 Jul; 194(1):99-106. PubMed ID: 11435476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic Silencing of
    Montanari M; Carbone MR; Coppola L; Giuliano M; Arpino G; Lauria R; Nardone A; Leccia F; Trivedi MV; Garbi C; Bianco R; Avvedimento EV; De Placido S; Veneziani BM
    Mol Cancer Res; 2019 Feb; 17(2):628-641. PubMed ID: 30242055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.